A comprehensive view of Vir Biotechnology Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Vir Biotechnology and GSK Plc end a part of their joint effort to develop a flu treatment following disappointing results from a Phase 2 study of the flu shot VIR-2482; Vir retains sole development rights
Published: February 27, 2024 by Marketline - Deals
National Institutes of Health begins phase 1 trial of preventive HIV vaccine VIR-1388 in the US and South Africa, designed to stimulate HIV-specific immune response; trial funded by the Bill & Melinda Gates Foundation and Vir Biotechnology
Published: September 21, 2023 by Infection Control Today

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count